Cerence (CRNC) Earnings Analysis
Cerence (CRNC) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS 0.15 USD vs 0.136 USD est (+10.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -20.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CRNC next report earnings?
No confirmed upcoming earnings date is currently scheduled for CRNC. This page updates as the calendar is published.
CRNC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.15 USD | 0.136 USD | +10.3% | Beat |
| 2026-02-04 | 0.99 USD | 0.115 USD | +760.9% | Beat |
| 2025-11-19 | 0.06 USD | -0.66 USD | +109.1% | Beat |
| 2025-02-06 | -0.03 USD | -0.27 USD | +88.9% | Beat |
| 2024-11-21 | -0.07 USD | -0.36 USD | +80.6% | Beat |
| 2024-08-08 | 0.19 USD | 0.05 USD | +280% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
CRNC valuation and analyst view
| Trailing P/E | -20.97 |
|---|---|
| Trailing EPS | -0.4357 USD |
| Price / book | 2.72 |
| Dividend yield | 0.00% |
| Market cap | 0.43B |
| Analyst consensus | Hold (3 buy / 10 hold / 0 sell) |
| Avg price target | 9.5 USD |
Related research pages
Frequently asked questions
When is Cerence (CRNC)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CRNC. This page updates as the calendar is published.
Did CRNC beat earnings last quarter?
In its 2026-05-07 report, CRNC posted EPS of 0.15 USD versus a 0.136 USD estimate — a beat of 10.3%.
What is CRNC's earnings track record?
Over the last 6 reported quarters with consensus data, CRNC beat estimates 6 times (100%).
What is CRNC's current P/E ratio and EPS?
CRNC trades at a trailing P/E of -20.97 on trailing EPS of -0.43570240603171084 USD.
What do analysts rate CRNC?
Analyst consensus is "Hold" across 13 ratings (0 strong buy, 3 buy, 10 hold, 0 sell, 0 strong sell). Average 12-month price target: 9.5 USD.